Primo, you may be right for now, but not for much longer. It looks like EHR will get the jump on all their ASX listed peers. Recently announced $US134m finance for their Copahue project. Combine that with agreements to sell 40MWe per annum and you've got a company with a confirmed resource, secure funding, and a market to sell to. With the project to commence early 2012, we could see power and revenue in 2013 for EHR. As always DYOR.
- Forums
- ASX - By Stock
- RNE
- agm
agm, page-5
Featured News
Add RNE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.727M |
Open | High | Low | Value | Volume |
0.1¢ | 0.1¢ | 0.1¢ | $19.02K | 19.02M |
Featured News
RNE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online